Human Complement C4 Deficient EDTA Plasma

<strong>Human Complement C4 Deficient EDTA Plasma</strong>_x000D_ <strong>Catalog number:</strong> B2015086_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 mL_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Palsma_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20° C_x000D_ <strong>Keywords:</strong> Complement Component 4, Complement Component IV, C4, CIV, Acidic C4, Acidic Complement C4, Basic C4, C3 and PZP-like alpha-2-Macroglobulin Domain-containing Protein 2, C4 Anaphylatoxin, C4 Propeptide_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Biancone L, David S, Della Pietra V, Montrucchio G, Cambi V, Camussi G. Alternative pathway activation of complement by cultured human proximal tubular epithelial cells Kidney Int. 1994 Feb;45(2):451-60._x000D_ 2: Pilely K, Skjoedt MO, Nielsen C, Andersen TE, Louise Aabom A, Vitved L, Koch C, Skjødt K, Palarasah Y. A specific assay for quantification of human C4c by use of an anti-C4c monoclonal antibody J Immunol Methods. 2014 Mar;405:87-96._x000D_ 3: Farkas P, Csuka D, Mikes B, Sinkovits G, Réti M, Németh E, Rácz K, Madách K, Gergely M, Demeter J, Prohászka Z. Complement activation, inflammation and relative ADAMTS13 deficiency in secondary thrombotic microangiopathies Immunobiology. 2017 Feb;222(2):119-127._x000D_ 4: Larcher VF, Wyke RJ, Vergani D, Mowat AP, Williams R. Yeast opsonisation and complement in children with liver disease. Analysis of 69 cases Pediatr Res. 1983 Apr;17(4):296-300._x000D_ 5: Fields T, Ghebrehiwet B, Kaplan AP. Kinin formation in hereditary angioedema plasma: evidence against kinin derivation from C2 and in support of "spontaneous" formation of bradykinin J Allergy Clin Immunol. 1983 Jul;72(1):54-60._x000D_ 6: Rajagopalan R, Nyaundi T, Salvi VP, Rawal N. Recombinant form of human wild type mannan-binding lectin (MBL/A) but not its structural variant (MBL/C) promotes phagocytosis of zymosan by activating complement Mol Immunol. 2010 Sep;47(15):2505-14._x000D_ 7: Bergamaschini L, Canziani S, Bottasso B, Cugno M, Braidotti P, Agostoni A. Alzheimer's beta-amyloid peptides can activate the early components of complement classical pathway in a C1q-independent manner Clin Exp Immunol. 1999 Mar;115(3):526-33._x000D_ 8: Metin A, Sanal O, Ersoy F, Tezcan I, Berkel AI, Irkeç C. Polymorphism of the fourth component of complement in Turks Hum Biol. 2000 Jun;72(3):527-33._x000D_ 9: Doxiadis G, Doxiadis I, Grosse-Wilde H. Polymorphism of human C2 detected by immunoblotting Hum Genet. 1985;70(4):355-8._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/2477464">10: Hintner H, Stanzl U, Dahlbäck K, Dahlbäck B, Breathnach SM. Vitronectin shows complement-independent binding to isolated keratin filament aggregates J Invest Dermatol. 1989 Nov;93(5):656-61. </a>_x000D_ _x000D_ <strong>Products Related to Human Complement C4 Deficient EDTA Plasma can be found at</strong> <a href="https://moleculardepot.com/product-category/Biofluids/"> Biofluids</a>